scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1030928H |
P356 | DOI | 10.1371/JOURNAL.PONE.0130928 |
P932 | PMC publication ID | 4476721 |
P698 | PubMed publication ID | 26098642 |
P5875 | ResearchGate publication ID | 280032198 |
P50 | author | Katsunobu Hagihara | Q54234768 |
P2093 | author name string | Takashi Izumi | |
Noriko Okudaira | |||
Makoto Hirasawa | |||
P2860 | cites work | Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis | Q61781514 |
Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs | Q82663150 | ||
Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes | Q83492372 | ||
Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide | Q24630127 | ||
Idiosyncratic adverse drug reactions: current concepts | Q26824391 | ||
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire | Q27681301 | ||
Lapatinib plus capecitabine for HER2-positive advanced breast cancer | Q27851403 | ||
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 | ||
A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket | Q33258637 | ||
Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules | Q33324394 | ||
Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation | Q34063488 | ||
Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity | Q34140322 | ||
Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury | Q35136429 | ||
Pharmacological interaction of drugs with immune receptors: the p-i concept. | Q36639657 | ||
Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy | Q42548860 | ||
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer | Q43270036 | ||
HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer | Q46575159 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0130928 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01 | |
P478 | volume | 10 |
Q41640449 | Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib |
Q38824550 | Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature |
Q92432175 | HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis |
Q42289978 | In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01. |
Q55667533 | Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex. |
Search more.